Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge

2 days ago 3

Vandita Jadeja

Thu, May 14, 2026 astatine 12:00 PM CDT 4 min read

Quick Read

CVS Health (CVS) posted Q1 adjusted EPS of $2.57, beating statement by 36%, portion Aetna’s wellness benefits operating income surged 52.6% arsenic the aesculapian payment ratio improved to 84.6% from 87.3%.
Management raised full-year adjusted EPS guidance to $7.30-$7.50 and operating currency travel to astatine slightest $9.5 billion. 24/7 Wall St. issued a bargain standing with a $125.45 terms target, implying 44.43% upside.
Aetna’s borderline betterment is executing up of program aft the idiosyncratic speech exit removes a money-losing segment, portion Caremark maintains high-90s lawsuit retention and launches Health100 connected Google Cloud to thrust engagement.
The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and CVS Health wasn't 1 of them. Get them present FREE.

Our 24/7 Wall St. terms people for CVS Health (NYSE:CVS) is $125.45, pointing to meaningful upside from wherever shares commercialized today. The banal closed astatine $86.86 connected May 6, aft a 7.65% single-day popular connected Q1 earnings. Our exemplary implies 44.43% upside implicit the adjacent 12 months, and we are issuing a bargain standing with precocious confidence.

24/7 Wall St. Price Target Summary

Metric

Value

Current Price	$86.86
24/7 Wall St. Price Target	$125.45
Upside	44.43%
Recommendation	BUY
Confidence Level	90%

An infographic titled 'CVS Health 12-Month Price Prediction: THE CALL'. It displays the Current Price of $86.86, an upward greenish arrow, and a Target Price of $125.45, with a +44.43% Upside and a 'BUY' recommendation. A assurance level of 90% (High) is stated. The 'HOW WE GOT THERE' conception shows a barroom illustration for Valuation Components & Weighted Contributions, including Trailing P/E-Based Price ($86.86), Forward P/E-Based Price ($119.90), and Analyst Consensus ($96.65), resulting successful a Weighted Base of $106.32. The 'OUR ADJUSTMENTS' conception visualizes factors similar 247Factor Adjustment (1.18x), Healthcare Sector Momentum, Bullish Analyst Consensus, Accelerating Earnings Growth, and Low Volatility (Beta 0.59), starring to the Final Target Price of $125.45. The 'BULL CASE' conception lists 4 affirmative factors: Aetna Margin Recovery, Exit of Individual Exchange Business, Caremark Client Wins & Retention, and Health100 Tech Launch & AI, with a Bull Case Target of $141.86 (+63.32%). The 'BEAR CASE' conception lists 4 antagonistic factors: Pharmacy Reimbursement Pressure, Regulatory Drug Price Reductions, Health Services Margin Compression, and Medical Membership Decline, with a Bear Case Target of $103.01 (+18.6%). The 'THE BOTTOM LINE' conception reiterates 'BUY $125.45 (+44.43%)' and provides a summary statement: 'Strong execution and borderline betterment thrust raised guidance, supporting important upside.'

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and CVS Health wasn't 1 of them. Get them present FREE.

Aetna's Margin Snapback Just Reset the CVS Story

CVS has been 1 of the strongest large-cap healthcare names of the past year, gaining 35.88% implicit the past 12 months and 19.53% successful conscionable the past month. Shares present beryllium adjacent the 52-week precocious of $88.63 aft rebounding sharply from the $56.29 low.

The catalyst was a cleanable Q1 2026 net study connected May 6. CVS posted adjusted EPS of $2.57 against a $2.21 consensus, the 4th consecutive beat. Revenue roseate 6.2% to $100.4 billion. The header was Aetna: Health Care Benefits adjusted operating income jumped 52.6% to $3.04 billion, with the aesculapian payment ratio improving to 84.6% from 87.3%. Management raised full-year adjusted EPS guidance to $7.30 to $7.50 and operating currency travel to astatine slightest $9.5 billion.

The Bull Case

The bull lawsuit is straightforward. If Aetna's MBR continues compressing and the idiosyncratic speech exit removes a money-losing drag, FY2026 EPS could onshore adjacent the precocious extremity oregon supra the $7.50 guide. Caremark is winning clients with high-90s retention, and the Health100 motorboat connected Google Cloud opens a caller tech-enabled engagement layer.

Morningstar's Julie Utterback raised her just worth to $105 from $97 aft the net report. The Street statement sits astatine $96.65 with 24 buys, 3 holds, and zero sells. BofA raised the firm's terms people connected CVS Health to $100 from $95 and keeps a Buy standing connected the shares aft the institution reported a Q1 bushed with revenue, EBIT, and EPS supra statement expectations. Further, UBS raised the firm's terms people to $100 from $97 and keeps a Buy standing connected the shares.

Read Entire Article